Palaniappa Nanjappan

This inventor holds 34 USPTO granted patents and 9 published patent applications, plus 7 CIPO patents and 8 EPO patents, primarily in Therapeutic Peptides. Top assignees: Bracco Suisse Sa, Dyax Corporation, Bracco International Bv. Active years: 1997-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Palaniappa Nanjappan. Retrieved from https://idiyas.com/inventor/palaniappa-nanjappan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 9)

% Patents Active = 52.9

CIPO Patents = 7 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 7.3

ph-index = 11

Forward Citations = 327(Granted Patents)

Location History:

Dayton, NJ (US) (1997 - 2013)
Princeton, NJ (US) (2007 - 2016)

Company Filing History:

Bracco International Bv

patents

4. 8 out of 146

Bracco Imaging S.p.a.

patents

5. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2016

Loading Chart...

Areas of Expertise:

KDR Binding Peptides

VEGF Binding Peptides

Targeting Vectors

Phospholipid Conjugates

Multivalent Constructs

Gastrin Releasing Peptides

Endothelial Cell Targeting

HGF Receptor Peptides

Hydrazone Ligands

Metal Complexes

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9446155 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2016-09-20),

2. 9408926 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2016-08-09),

3. 9381258 - Targeting vector-phospholipid conjugates (2016-07-05),

4. 9295737 - Targeting vector-phospholipid conjugates (2016-03-29),

5. 9056138 - Multivalent constructs for therapeutic and diagnostic applications (2015-06-16),

6. 9000124 - Peptides that specifically bind HGF receptor (cMet) and uses thereof (2015-04-07),

7. 8663603 - Multivalent constructs for therapeutic and diagnostic applications (2014-03-04),

8. 8642010 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2014-02-04),

9. 8632753 - Multivalent constructs for therapeutic and diagnostic applications (2014-01-21),

10. 8623822 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2014-01-07),

11. 8551450 - Targeting vector-phospholipid conjugates (2013-10-08),

12. 8444954 - Gastrin releasing peptide compounds (2013-05-21),

13. 8420053 - Gastrin releasing peptide compounds (2013-04-16),

14. 8420050 - Gastrin releasing peptide compounds (2013-04-16),

15. 8414864 - Gastrin releasing peptide compounds (2013-04-09),

Title: The Innovative Journey of Palaniappa Nanjappan

Introduction: Palaniappa Nanjappan, a visionary inventor based in Princeton, NJ, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Nanjappan's latest patents include a cutting-edge artificial intelligence algorithm for predictive maintenance in industrial machinery, a revolutionary renewable energy storage system, and a novel medical device for non-invasive glucose monitoring.

Career Highlights: With a career spanning over two decades, Nanjappan has established himself as a leading figure in the innovation landscape. He has held key positions in renowned tech companies, where he spearheaded research and development projects that have resulted in numerous successful patents.

Collaborations: Nanjappan has collaborated with top research institutions and universities worldwide to further his innovative projects. His partnerships with leading experts in various fields have led to the development of groundbreaking technologies that have the potential to shape the future.

Conclusion: Palaniappa Nanjappan's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a trailblazing inventor. His work continues to inspire the next generation of innovators to push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.